Chemical pharmaceutical preparation industry has always been the dominant sub-industry in China's pharmaceutical industry, with the characteristics of high technology content, high capital investment, high risk, high income and relative monopoly. In terms of the value chain, chemical preparations are at the high end of the value chain, which are generic drugs (generic drugs) and patented drugs in order of increasing value, and patented drugs are the top of the whole value chain.
chemical preparations are related to national health, social stability and economic development, and are a special and important industry in the national economy. Since the reform and opening up 3 years ago, the development of China's chemical preparation industry has entered the fast lane. In recent years, the growth rate of total industrial output value has remained above 18%, and the growth rate of sales revenue has basically remained above 2%. From the development trend, the chemical preparation industry is about to enter a period of rapid development, and there is huge room for future development, but the profit distribution will be more uneven, and the industry concentration will be further improved. Enterprises with R&D, scale and product advantages will become stronger.
China's chemical preparation industry has completely developed into a competitive industry, and its international influence has also been improved. In mainland China, the market competition between foreign-funded and joint-venture pharmaceutical enterprises and domestic-funded pharmaceutical enterprises is very fierce. Especially in recent two or three years, foreign-funded and joint-venture pharmaceutical enterprises have greatly increased their investment in China and strengthened their market strength. By the end of 211, there were 1,32 chemical preparation enterprises above designated size in Chinese mainland. After the rapid development stage and fierce market competition, the basic pattern was initially formed. Foreign-funded and joint-venture pharmaceutical companies occupy the high-end market of chemical preparations in China, but domestic brands are gradually entering the high-end market.
in recent years, the shift of the focus of the international pharmaceutical market to generic drugs and the rapid growth of the production capacity of China's chemical preparation industry have become an important thrust for the export of chemical preparations, and the export of pharmaceutical products has warmed up. According to the data of Medical Insurance Chamber of Commerce, in 211, the export value of China's chemical preparation industry reached US$ 2.174 billion, a year-on-year increase of 4.2%. At the same time, according to the statistics of China Chemical Pharmaceutical Industry Association, many pharmaceutical companies in China have passed the GMP certification of the United States and the European Union, and are qualified to export pharmaceutical products to these high-end markets, showing good development prospects.
in the future, the chemical industry will be divided, and the characteristics of R&D enterprises and production enterprises will gradually become obvious. At the same time, with the expiration of foreign patented drugs, "heavy" drugs have become the target of imitation enterprises, which provides a good guide for the industry to develop in the direction of generic drugs, and the development of generic drugs faces good opportunities. In addition, the research and development period of new drugs is long, the investment is high, and the risks are high. However, the drug controlled-release technology and chiral drug development based on the chemical structure of existing drugs do not have the above risks, and may become the focus of future technology development.